Periprosthetic osteolysis and its association with RANKL expression
Language English Country Czech Republic Media print-electronic
Document type Journal Article
PubMed
16925460
DOI
10.33549/physiolres.930997
PII: 997
Knihovny.cz E-resources
- MeSH
- Femur chemistry pathology MeSH
- Hip Joint surgery MeSH
- Hip Prosthesis * MeSH
- Middle Aged MeSH
- Humans MeSH
- RANK Ligand analysis MeSH
- Arthroplasty, Replacement, Hip adverse effects instrumentation MeSH
- Osteolysis etiology metabolism pathology surgery MeSH
- Reoperation MeSH
- Prosthesis Failure * MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- RANK Ligand MeSH
- TNFSF11 protein, human MeSH Browser
Extensive osteolysis adjacent to orthopedic implants is often associated with wear particles of prosthetic material. The activation of the RANKL/RANK/OPG system is considered to be a likely cause of periprosthetic osteolysis leading to implant failure. The aim of this study was to examine the possible correlation between the clinical extent of osteolysis, the number of wear particles and expression of the osteoclastic mediator RANKL (receptor activator of nuclear factor kappa B ligand) in the tissues around aseptically loosened cemented and non-cemented total hip replacements. Periprosthetic tissues were harvested from 59 patients undergoing revision of hip replacement for aseptic loosening. We observed RANKL-positive cells in 23 of our 59 patients, their presence was noted predominantly in tissues with a loosened cemented endoprosthesis. We have found that RANKL is present only in tissues with a large amount of wear debris and predominantly in cases involving loosened cemented implants.
References provided by Crossref.org
Periprosthetic Osteolysis: Mechanisms, Prevention and Treatment